최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of veterinary clinics = 한국임상수의학회지, v.23 no.2 = no.53, 2006년, pp.202 - 206
임영환 (충남대학교 수의과대학) , 이정연 (일본 오비히로 축산대학) , 조성남 (충남대학교 수의과대학) , 박성준 (충남대학교 수의과대학) , 최호정 (충남대학교 수의과대학) , 이영원 (충남대학교 수의과대학) , 송근호 (충남대학교 수의과대학)
A 7-year-old, spayed female, Yorkshire terrier dog with polyuria/polydipsia (PU/PD), interdigital edema, pruritus and abdominal enlargement was referred to the Veterinary Medical Teaching Hospital of the present university. Pituitary-dependent hyperadrenocortisim (PDH) was diagnosed by clinical sign...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Behrend EN, Kemppainen RJ, Clark TP, Salman MD, Peterson ME. Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists. J Am Vet Med Assoc 1999; 215: 938-943
Braddock JA. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticis. Aust Vet J 2003; 81: 600-607
DeClue AE, Cohn LA, Kerl ME. Medical therapies for canine pituitary dependent hyperadrenocorticism. Vet Med 2004: 519-527
Jenkin G, Gemmell RT, Thorburn GD. Induction of transient functional luteolysis in cyclic sheep by a 3 $\beta$ -hydroxysteroid dehydrogenase inhibitor. J Endocrinol 1984; 100: 61-66
Kintzer PP, Peterson ME. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1991; 5: 182-190
Ie Roux PA, van der Spuy ZM. Labor induction abortion utilizing trilostane, a 3 $\beta$ -hydroxysteroid dehydrogenase inhibitor. Contraception 2005; 71: 343-347
Neiger R, Ramsey I, O'Connor J, Hurley KJ, Mooney CT. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002; 150: 799-804
Nelson RW, Couto CG. Disorder of the adrenal gland. In: Small animal internal medicine, 3rd ed. Philadelphia: Mosby. 2003: 779-798
Peterson ME, Altszuler N, Nichols CE. Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism. Res Vet Sci 1984; 36: 177-182
Peterson ME, Kintzer PP. Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane. Vet Clin North Am Small Anim Pract 1997; 27: 255-272
Reusch CE. Hyperadrenocorticism. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine, 6th ed. St. Louis: Elsevier Saunders, 2005: 1592-1612
Reusch CE, Steffen T, Hoerauf A. The efficacy of L-Deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1999; 13: 291-301
Rijnberk A, Belshaw BE. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism. Vet Rec 1988; 122: 486-488
Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002: 63: 506-512
Schechter RD, Stabenfeldt GH, Gribble DH, Ling GV. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD). J Am Vet Med Assoc 1973; 162: 629-639
Song JW, Park HM. Mitotane therapy and management of naturally occurring pituitary dependent hyperadrenocorticism (PDH) in a dog. J Vet Sci 2003; 20: 233-236
차봉수. Pathophysiology로 이해하는 내과학. 서울: 정담출판. 2002: 85-101
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.